MedExam CompassFree questions
Shock types

[Case Study 1, Screen 2: 1000 nurses' notes, vital signs, prescriptions, and IV access.] Which action should the nurse take?

CLIENT
63-year-old woman. Weight 70 kg.
History: type 2 diabetes (takes metformin), hypertension (takes lisinopril).
Lives with spouse; independent in all activities; baseline fully oriented.
Home blood pressure readings usually about 132/78 mm Hg.

NURSES' NOTES - 0800
Spouse reports the client has been "sleepy and confused" since last night.
Client reports burning on urination for 3 days and has been eating and
drinking very little for 2 days. Oriented to person only. Skin warm and
flushed; mucous membranes dry. Reports right flank pain, 5/10. Lungs clear
bilaterally. Capillary refill 3 seconds. Last voided a small amount of dark
urine early this morning.

VITAL SIGNS - 0800
Temperature      39.0°C (102.2°F)
Heart rate       116/min
Respiratory rate 24/min
Blood pressure   88/50 mm Hg (MAP 63 mm Hg)
SpO2             95% on room air

LABORATORY RESULTS - 0815            Result            Reference range
WBC                                  18,600/mm³        5,000-10,000/mm³
  Bands                              14%               0-5%
Lactate                              4.1 mmol/L        0.5-2.0 mmol/L
Creatinine                           1.9 mg/dL         0.5-1.1 mg/dL
  (baseline 1 month ago: 0.9 mg/dL)
BUN                                  40 mg/dL          7-20 mg/dL
Glucose (random)                     238 mg/dL         70-140 mg/dL
Sodium                               137 mEq/L         135-145 mEq/L
Potassium                            4.6 mEq/L         3.5-5.0 mEq/L
Platelets                            172,000/mm³       150,000-400,000/mm³
Urinalysis: cloudy; nitrite positive; leukocyte esterase positive;
            WBC more than 50/hpf


NURSES' NOTES - 1000
Blood cultures x2 drawn at 0820. Piperacillin-tazobactam IV started at 0835.
Lactated Ringer's solution 2,100 mL IV completed at 0955. Client is lethargic
but arousable. Extremities cool. Indwelling urinary catheter inserted at 0830;
25 mL of urine since insertion.

VITAL SIGNS - 1000
Temperature      38.6°C (101.5°F)
Heart rate       124/min
Respiratory rate 26/min
Blood pressure   80/44 mm Hg (MAP 56 mm Hg)
SpO2             94% on room air

PROVIDER PRESCRIPTIONS - 1000
- Norepinephrine continuous IV infusion; titrate to maintain MAP at or
  above 65 mm Hg.
- Central venous catheter insertion when the provider is available
  (estimated 1 to 2 hours).

IV ACCESS
- 18-gauge peripheral IV, right upper forearm (proximal, below the elbow
  crease): patent, no redness or swelling.
- 20-gauge peripheral IV, dorsum of left hand: patent.
  1. AHold the norepinephrine until the central venous catheter has been inserted.
  2. BStart the norepinephrine through the 18-gauge right proximal forearm IV and monitor the site closely.
  3. CStart the norepinephrine through the 20-gauge left hand IV so the forearm line remains available for other infusions.
  4. DInfuse another 2,000 mL of lactated Ringer's solution and hold the norepinephrine until it is complete.
Show answer and explanations

Answer

B

A: Waiting for central access can prolong dangerous hypotension. B: An 18-gauge IV in a proximal upper-forearm vein, away from flexion sites, permits prompt vasopressor initiation with close site monitoring while central access is arranged. C: Peripheral vasopressors are best given through a large-bore IV in a larger, more proximal vein; a smaller 20-gauge IV in the hand is a distal site with higher extravasation risk. D: An automatic extra large bolus before vasopressor therapy can delay needed support and needs reassessment.

A

Waiting for central access can prolong dangerous hypotension.

B

An 18-gauge IV in a proximal upper-forearm vein, away from flexion sites, permits prompt vasopressor initiation with close site monitoring while central access is arranged.

C

Peripheral vasopressors are best given through a large-bore IV in a larger, more proximal vein; a smaller 20-gauge IV in the hand is a distal site with higher extravasation risk.

D

An automatic extra large bolus before vasopressor therapy can delay needed support and needs reassessment.

Take the free 30-question test

ID: Q53